Drug Channels delivers timely analysis and provocative opinions from Adam J. Fein, Ph.D., the country's foremost expert on pharmaceutical economics and the drug distribution system. Drug Channels reaches an engaged, loyal and growing audience of more than 100,000 subscribers and followers. Learn more...

Friday, August 01, 2025

The AI Advantage: Evolving Patient Engagement Strategies to Improve Outcomes

Today’s guest post comes from Stacey Little, Chief Growth Officer at AssistRx.

In this guest post, Stacey explores how artificial intelligence (AI) is helping life sciences organizations move beyond fragmented support models to deliver more integrated and personalized patient engagement. She outlines three distinct approaches to structuring patient support programs and discusses how AI-driven tools—such as AllazoHealth—can help tailor interventions across the entire treatment journey.

To learn more, see the AssistRx case study: Sophisticated Patient Engagement Programs that Improve Experiences and Outcomes.

Read on for Stacey’s insights.